Meeting NewsVideo

VIDEO: Progress report on Cequa in dry eye market

KOLOA, Hawaii — At Hawaiian Eye 2020, Ryan Bleeks, of Sun Ophthalmics, shares an update on Cequa (cyclosporine ophthalmic solution 0.09%), launched in October 2019 for the treatment of dry eye disease. “Our team is extremely fired up because of how well this has been accepted,” Bleeks said. “There was a real need, I think, for another player in the dry eye market.”

Disclosure: Bleeks is the national sales director at Sun Ophthalmics.

KOLOA, Hawaii — At Hawaiian Eye 2020, Ryan Bleeks, of Sun Ophthalmics, shares an update on Cequa (cyclosporine ophthalmic solution 0.09%), launched in October 2019 for the treatment of dry eye disease. “Our team is extremely fired up because of how well this has been accepted,” Bleeks said. “There was a real need, I think, for another player in the dry eye market.”

Disclosure: Bleeks is the national sales director at Sun Ophthalmics.

    See more from Hawaiian Eye/Retina Meeting